期刊文献+

Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma 被引量:14

Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma
下载PDF
导出
摘要 AIM: To investigate the expression of cyclooxygenase-2 (COX-2) and epithelial growth factor receptor (EGFR) throughout the progression of Barrett's esophagus (BE). METHODS: COX-2 and EGFR protein expressions were detected by using immunohistochemical method. A detailed cytomorphological changes were determined. Areas of COX-2 and EGFR expression were quantified by using computer Imaging System. RESULTS: The expressions of both COX-2 and EGFR increased along with the progression from BE to esophagus adenocarcinoma (EAC). A positive correlation was found between COX-2 expression and EGFR expression. CONCLUSION: COX-2 and EGFR may be cooperative in the stepwise progression from BE to EAC, thereby leading to carcinogenesis. 瞄准:在整个 Barretts 食管的前进调查 cyclooxygenase-2 (COX-2 ) 和上皮的生长因素受体(EGFR ) 的表示() 。方法:COX-2 和 EGFR 蛋白质表情被使用免疫检测组织化学的方法。详细 cytomorphological 改变的 A 是坚定的。COX-2 和 EGFR 表示的区域被使用计算机成像系统确定。结果:COX-2 和 EGFR 的表情与前进一起增加了从到食管腺癌(EAC ) 。积极关联在 COX-2 表示和 EGFR 表示之间被发现。结论:COX-2 和 EGFR 可能在逐步的前进从是合作的到 EAC,从而导致致癌作用。
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第6期928-934,共7页 世界胃肠病学杂志(英文版)
基金 Supported by the University of Louisville Hospital the Society for Surgery of the Alimentary Tract Career Development Award
关键词 Cycloxygenase -2 (COX-2) Epithelial growth factor receptor (EGFR) Barrett's esophagus CARCINOGENESIS 上皮生长因子受体 环氧合酶 食管疾病 食管癌
  • 相关文献

参考文献38

  • 1[1]Blot WJ,Devesa SS,Kneller RW,Fraumeni JF Jr.Rising incidence of adenocarcinoma of the esophagus and gastric cardia.JAMA 1991; 265:1287-1289
  • 2[2]Pera M,Cameron AJ,Trastek VF,Carpenter HA,Zinsmeister AR.Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction.Gastroenterology 1993; 104:510-513
  • 3[3]Farrow DC,Vaughan TL.Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States).Cancer Causes Control 1996; 7:322-327
  • 4[4]Isolauri J,Luostarinen M,Isolauri E,Reinikainen P,Viljakka M,Keyrilainen O.Natural course of gastroesophageal reflux disease:17-22 year follow-up of 60 patients.Am J Gastroenterol 1997; 92:37-41
  • 5[5]Altorki NK,Oliveria S,Schrump DS.Epidemiology and molecular biology of Barrett's adenocarcinoma.Semin Surg Oncol 1997; 13:270-280
  • 6[6]Geboes K.Barrett's esophagus:the metaplasia-dysplasiacarcinoma sequence:morphological aspects.Acta Gastroenterol Belg 2000; 63:13-17
  • 7[7]Jankowski JA,Wright NA,Meltzer SJ,Triadafilopoulos G,Geboes K,Casson AG,Kerr D,Young LS.Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.Am J Pathol 1999; 154:965-973
  • 8[8]Hanahan D,Weinberg RA.The hallmarks of cancer.Cell 2000;100:57-70
  • 9[9]Yarden Y.The EGFR family and its ligands in human cancer.signalling mechanisms and therapeutic opportunities.Eur J Cancer 2001; 37 Suppl 4:S3-S8
  • 10[10]Salomon DS,Brandt R,Ciardiello F,Normanno N.Epidermal growth factor-related peptides and their receptors in human malignancies.Crit Rev Oncol Hematol 1995; 19:183-232

同被引文献60

引证文献14

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部